Publicaciones en colaboración con investigadores/as de University of Glasgow (13)

2014

  1. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: Design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial

    Journal of Hypertension, Vol. 32, Núm. 9, pp. 1888-1897

  2. Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: A review of available trial evidence

    Journal of Hypertension, Vol. 32, Núm. 9, pp. 1741-1750

2013

  1. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

    European Heart Journal, Vol. 34, Núm. 28, pp. 2159-2219

2007

  1. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension

    Journal of Hypertension, Vol. 25, Núm. 9, pp. 1751-1762

  2. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

    Journal of Hypertension, Vol. 25, Núm. 6, pp. 1105-1187

  3. 2007 Guidelines for the management of arterial hypertension

    European Heart Journal, Vol. 28, Núm. 12, pp. 1462-1536

  4. ESH/ESC 2007 guidelines for the management of arterial hypertension

    Revista Espanola de Cardiologia, Vol. 60, Núm. 9

  5. Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial

    Journal of Hypertension, Vol. 25, Núm. 7, pp. 1473-1479

2005

  1. Angiotensin-II receptor blockers: Benefits beyond blood pressure reduction?

    Journal of Human Hypertension, Vol. 19, Núm. 5, pp. 331-339

2002

  1. Design of the omapatrilat in persons with enhanced risk of atherosclerotic events (opera) trial

    American Journal of Hypertension, Vol. 15, Núm. 2 I, pp. 193-198

2001

  1. Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study

    Journal of Hypertension, Vol. 19, Núm. 6, pp. 1149-1159

1998

  1. Risk factors associated with alterations in carotid intima-media thickness in hypertension: Baseline data from the European Lacidipine Study on Atherosclerosis

    Journal of Hypertension, Vol. 16, Núm. 7, pp. 949-961

1995

  1. Potential modification of plaque behavior through the european lacidipine study on atherosclerosis

    Journal of Cardiovascular Pharmacology, Vol. 25, pp. S11-S16